FDA 483 - Clongen Laboratories LLC

An FDA inspection of Clongen Laboratories, LLC in Gaithersburg, MD, a release testing facility, revealed significant deficiencies in quality oversight, written procedures, equipment qualification, and quality control practices. The firm also lacked adequate employee training and a critical quality agreement for mycoplasma release testing. These findings indicate a broad failure to maintain a state of control over laboratory operations.